Gout Therapeutics Market Key Vendors (Companies) Global Analysis and Forecast to 2020
ReportsnReports.com adds a new research report Global Gout Therapeutics Market 2016-2020. This report covers the present scenario and the growth prospects of the global gout therapeutics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used for the treatment of gout and the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs.
This analyst forecast the global gout therapeutics market to grow at a CAGR of 17.16% during the period 2016-2020.
Complete report available @ http://www.reportsnreports.com/reports/738716-global-gout-therapeutics-market-2016-2020.html
Gout is one type of arthritis, which is caused by the high levels of uric acid in the blood. The main symptoms of gout are sudden attack of burning pain, swelling in a joint, and stiffness, usually in toe. If it is not treated, over time, it can harm tendons, joints, and other tissues. NSAIDs and urate-lowering agents are preferred treatment options for gout.
The report, Global Gout Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. This report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
For More Information Inquire at http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=738716
Key vendors
- AstraZeneca
- Horizon Pharma
- Takeda Pharmaceuticals
Other prominent vendors
- Ablynx
- Alder Biopharmaceuticals
- Antares Pharma
- Astellas Pharma
- Boehringer Ingelheim
- Can-Fite BioPharma
- Celgene
- Celltrion
- ChemoCentryx
- CymaBay Therapeutics
- Eisai
- Eli Lilly
- Gilead Sciences
- GlaxoSmithKline
- Incyte
- Ironwood Pharmaceuticals
- JW Pharmaceutical
- KaloBios Pharmaceuticals
- Lexicon Pharmaceuticals
- LG Life Sciences
- Merck
- Morphotek
- Novartis
- Novo Nordisk
- Regeneron Pharmaceuticals
- Sandoz
- Sanofi
- Santarus
- Selecta Biosciences
- Teijin Pharma
- UCB
- Vertex Pharmaceuticals.
Market driver
- Introduction of novel urate-lowering agents
- For a full, detailed list, view our report
Market challenge
- Low physician and patient awareness
- For a full, detailed list, view our report
Market trend
- Focus on regenerative medicines
- For a full, detailed list, view our report
Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=738716
About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
